Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients
出版年份 2019 全文链接
标题
Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients
作者
关键词
-
出版物
OncoImmunology
Volume 8, Issue 11, Pages e1652540
出版商
Informa UK Limited
发表日期
2019-08-15
DOI
10.1080/2162402x.2019.1652540
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
- (2019) Gregor Hutter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
- (2019) Jordan Guillon et al. Cell Death & Disease
- Peritumoral Monocytes Induce Cancer Cell Autophagy to Facilitate the Progression of Human Hepatocellular Carcinoma
- (2018) Dong-Ping Chen et al. Autophagy
- Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma
- (2018) Chao-Qun Liu et al. BRITISH JOURNAL OF CANCER
- MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
- (2018) Wei Huang et al. Molecular Cancer
- Chemotherapy induces enrichment of CD47+/CD73+/PDL1+immune evasive triple-negative breast cancer cells
- (2018) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor mutational burden is a determinant of immune-mediated survival in breast cancer
- (2018) Alexandra Thomas et al. OncoImmunology
- NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice
- (2018) Shuang Liang et al. GASTROENTEROLOGY
- Surgical Resection vs . Transarterial Chemoembolization for Intermediate Stage Hepatocellular Carcinoma (BCLC-B): An Unsolved Question
- (2018) Ismail Labgaa et al. HEPATOLOGY
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is CD47 an innate immune checkpoint for tumor evasion?
- (2017) Xiaojuan Liu et al. Journal of Hematology & Oncology
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Localized CD47 blockade enhances immunotherapy for murine melanoma
- (2017) Jessica R. Ingram et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
- (2017) Sharareh Gholamin et al. Science Translational Medicine
- CD200R, a co-inhibitory receptor on immune cells, predicts the prognosis of human hepatocellular carcinoma
- (2016) Haoyu Sun et al. IMMUNOLOGY LETTERS
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
- (2016) Yoko Kojima et al. NATURE
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy
- (2016) Mario Roselli et al. OncoImmunology
- High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
- (2016) Cheng Sun et al. OncoImmunology
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
- (2015) Zhenyu Xiao et al. CANCER LETTERS
- Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice
- (2015) Jessica Lo et al. HEPATOLOGY
- Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
- (2015) Xavier Adhoute et al. JOURNAL OF HEPATOLOGY
- Anti-CD47 antibody suppresses tumour growth and augments the effect of chemotherapy treatment in hepatocellular carcinoma
- (2015) Jessica Lo et al. LIVER INTERNATIONAL
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- The origin and function of tumor-associated macrophages
- (2014) Yang Liu et al. Cellular & Molecular Immunology
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma
- (2014) Terence Kin-Wah Lee et al. HEPATOLOGY
- B7-H1–expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets
- (2014) Dong-Ming Kuang et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment of intermediate-stage hepatocellular carcinoma
- (2014) Alejandro Forner et al. Nature Reviews Clinical Oncology
- Tocilizumab versus adalimumab for rheumatoid arthritis
- (2013) David T Felson LANCET
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Tumor-associated macrophages: functional diversity, clinical significance, and open questions
- (2013) Subhra K. Biswas et al. Seminars in Immunopathology
- Roles Played by Chemolipiodolization and Embolization in Chemoembolization for Hepatocellular Carcinoma: Single-Blind, Randomized Trial
- (2012) Ming Shi et al. JNCI-Journal of the National Cancer Institute
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD47: a new player in phagocytosis and xenograft rejection
- (2011) Nalu Navarro-Alvarez et al. Cellular & Molecular Immunology
- Radiofrequency Ablation versus Surgical Resection as Primary Treatment of Hepatocellular Carcinoma Meeting the Milan Criteria: A Systematic Review
- (2011) Yun Ku Cho et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
- (2010) Dong-Ming Kuang et al. JOURNAL OF HEPATOLOGY
- A New Therapeutic Target for Leukemia Comes to the Surface
- (2009) David S. Ritchie et al. CELL
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
- (2009) Dong-Ming Kuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tocilizumab for rheumatoid and juvenile idiopathic arthritis
- (2008) Tim Bongartz LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now